Cargando…
Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial
BACKGROUND: Butorphanol slightly influences the respiratory and circulatory systems, has a better effect on relieving the discomfort caused by mechanical traction, and has a low incidence of postoperative nausea and vomiting (PONV). Combined butorphanol and propofol may suppress postoperative viscer...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044711/ https://www.ncbi.nlm.nih.gov/pubmed/36977981 http://dx.doi.org/10.1186/s12871-023-02053-9 |
_version_ | 1784913413989728256 |
---|---|
author | Wang, Jing Wang, Xinyan Liu, Haiyang Han, Ruquan |
author_facet | Wang, Jing Wang, Xinyan Liu, Haiyang Han, Ruquan |
author_sort | Wang, Jing |
collection | PubMed |
description | BACKGROUND: Butorphanol slightly influences the respiratory and circulatory systems, has a better effect on relieving the discomfort caused by mechanical traction, and has a low incidence of postoperative nausea and vomiting (PONV). Combined butorphanol and propofol may suppress postoperative visceral pain, which is avoidable in gastrointestinal endoscopy. Thus, we hypothesized that butorphanol could decrease the incidence of postoperative visceral pain in patients undergoing gastroscopy and colonoscopy. METHODS: This was a randomized, placebo-controlled, and double-blinded trial. Patients undergoing gastrointestinal endoscopy were randomized to intravenously receive either butorphanol (Group I) or normal saline (Group II). The primary outcome was visceral pain after the procedure 10 min after recovery. The secondary outcomes included the rate of safety outcomes and adverse events. Postoperative visceral pain was defined as a visual analog scale (VAS) score ≥ 1. RESULTS: A total of 206 patients were enrolled in the trial. Ultimately, 203 patients were randomly assigned to Group I (n = 102) or Group II (n = 101). In total, 194 patients were included in the analysis: 95 in Group I and 99 in Group II. The incidence of visceral pain at 10 min after recovery was found to be statistically lower with butorphanol than with the placebo (31.5% vs. 68.5%, respectively; RR: 2.738, 95% CI [1.409–5.319], P = 0.002), and the notable difference was in pain level or distribution of visceral pain (P = 0.006). CONCLUSIONS: The trial indicated that adding butorphanol to propofol results in a lower incidence of visceral pain after surgery without noticeable fluctuations in circulatory and respiratory functions for gastrointestinal endoscopy patients. TRIAL REGISTRATION: Clinicaltrials.gov NCT04477733 (PI: Ruquan Han; date of registration: 20/07/2020). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-023-02053-9. |
format | Online Article Text |
id | pubmed-10044711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100447112023-03-29 Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial Wang, Jing Wang, Xinyan Liu, Haiyang Han, Ruquan BMC Anesthesiol Research BACKGROUND: Butorphanol slightly influences the respiratory and circulatory systems, has a better effect on relieving the discomfort caused by mechanical traction, and has a low incidence of postoperative nausea and vomiting (PONV). Combined butorphanol and propofol may suppress postoperative visceral pain, which is avoidable in gastrointestinal endoscopy. Thus, we hypothesized that butorphanol could decrease the incidence of postoperative visceral pain in patients undergoing gastroscopy and colonoscopy. METHODS: This was a randomized, placebo-controlled, and double-blinded trial. Patients undergoing gastrointestinal endoscopy were randomized to intravenously receive either butorphanol (Group I) or normal saline (Group II). The primary outcome was visceral pain after the procedure 10 min after recovery. The secondary outcomes included the rate of safety outcomes and adverse events. Postoperative visceral pain was defined as a visual analog scale (VAS) score ≥ 1. RESULTS: A total of 206 patients were enrolled in the trial. Ultimately, 203 patients were randomly assigned to Group I (n = 102) or Group II (n = 101). In total, 194 patients were included in the analysis: 95 in Group I and 99 in Group II. The incidence of visceral pain at 10 min after recovery was found to be statistically lower with butorphanol than with the placebo (31.5% vs. 68.5%, respectively; RR: 2.738, 95% CI [1.409–5.319], P = 0.002), and the notable difference was in pain level or distribution of visceral pain (P = 0.006). CONCLUSIONS: The trial indicated that adding butorphanol to propofol results in a lower incidence of visceral pain after surgery without noticeable fluctuations in circulatory and respiratory functions for gastrointestinal endoscopy patients. TRIAL REGISTRATION: Clinicaltrials.gov NCT04477733 (PI: Ruquan Han; date of registration: 20/07/2020). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-023-02053-9. BioMed Central 2023-03-28 /pmc/articles/PMC10044711/ /pubmed/36977981 http://dx.doi.org/10.1186/s12871-023-02053-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Jing Wang, Xinyan Liu, Haiyang Han, Ruquan Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial |
title | Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial |
title_full | Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial |
title_fullStr | Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial |
title_full_unstemmed | Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial |
title_short | Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial |
title_sort | effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044711/ https://www.ncbi.nlm.nih.gov/pubmed/36977981 http://dx.doi.org/10.1186/s12871-023-02053-9 |
work_keys_str_mv | AT wangjing effectofbutorphanolonvisceralpaininpatientsundergoinggastrointestinalendoscopyarandomizedcontrolledtrial AT wangxinyan effectofbutorphanolonvisceralpaininpatientsundergoinggastrointestinalendoscopyarandomizedcontrolledtrial AT liuhaiyang effectofbutorphanolonvisceralpaininpatientsundergoinggastrointestinalendoscopyarandomizedcontrolledtrial AT hanruquan effectofbutorphanolonvisceralpaininpatientsundergoinggastrointestinalendoscopyarandomizedcontrolledtrial |